WallStreetZenWallStreetZen

NASDAQ: SLS
Sellas Life Sciences Group Inc Stock Ownership - Who owns Sellas Life Sciences Group?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sellas Life Sciences Group Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nostrand Robert L. VanDirector2025-06-1210,000$1.48
$14.80kBuy
Jane WasmanDirector2025-05-3020,000$1.69
$33.80kBuy
Katherine Bach KalinDirector2025-05-2220,000$1.80
$36.00kBuy
John Thomas BurnsCFO2024-12-047,165$1.13
$8.10kSell
Dragan CicicSVP Chief Development Officer2024-12-048,256$1.13
$9.33kSell
Angelos M. StergiouPresident and CEO2024-12-0428,289$1.13
$31.97kSell

1 of 1

SLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLS insiders and whales buy or sell their stock.

SLS Shareholders

What type of owners hold Sellas Life Sciences Group Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Anson Funds Management LP7.60%7,579,095$12.58MInstitution
Hudson Bay Capital Management LP4.41%4,400,000$7.30MInsider
Vanguard Group Inc2.85%2,839,318$4.71MInstitution
Robert Eugene Kennedy1.13%1,130,300$1.88MInsider
Angelos M. Stergiou0.86%859,032$1.43MInsider
Geode Capital Management LLC0.82%820,440$1.36MInstitution
Susquehanna International Group LLP0.69%688,696$1.14MInstitution
Blackrock Inc0.54%538,460$893.84kInstitution
Mark W. Schwartz0.44%439,978$730.36kInsider
Citadel Advisors LLC0.35%349,505$580.18kInstitution

1 of 3

SLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLS14.32%8.68%Net BuyingNet Buying
PBYI58.13%41.87%Net Selling
EDIT52.57%39.39%Net SellingNet Selling
ALDX63.26%27.92%Net SellingNet Selling
CYBN39.14%0.00%
View Top Biotech Stocks

Sellas Life Sciences Group Stock Ownership FAQ

Who owns Sellas Life Sciences Group?

Sellas Life Sciences Group (NASDAQ: SLS) is owned by 14.32% institutional shareholders, 8.68% Sellas Life Sciences Group insiders, and 77.00% retail investors. Hudson Bay Capital Management LP is the largest individual Sellas Life Sciences Group shareholder, owning 4.40M shares representing 4.41% of the company. Hudson Bay Capital Management LP's Sellas Life Sciences Group shares are currently valued at $7.30M.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.